# Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness

> **NCT00745771** · PHASE2 · COMPLETED · sponsor: **IDEA AG** · enrollment: 168 (actual)

## Conditions studied

- Muscle Soreness

## Interventions

- **DRUG:** Diractin
- **DRUG:** Diractin

## Key facts

- **NCT ID:** NCT00745771
- **Lead sponsor:** IDEA AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-02
- **Final completion:** 2008-11
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2009-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00745771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00745771, "Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00745771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*